Aura Biosciences, Inc. (AURA)
6.56
+0.27
(+4.29%)
USD |
NASDAQ |
Oct 20, 16:00
6.565
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences Market Cap : 678.83M for Oct. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 20, 2026 | 678.83M |
| October 19, 2026 | 650.89M |
| October 16, 2026 | 631.23M |
| October 15, 2026 | 656.06M |
| October 14, 2026 | 638.47M |
| October 13, 2026 | 648.82M |
| October 12, 2026 | 676.76M |
| October 09, 2026 | 676.76M |
| October 08, 2026 | 673.14M |
| October 07, 2026 | 668.48M |
| October 06, 2026 | 638.47M |
| October 05, 2026 | 643.65M |
| October 02, 2026 | 630.19M |
| October 01, 2026 | 625.02M |
| September 30, 2026 | 649.86M |
| September 29, 2026 | 636.40M |
| September 28, 2026 | 636.40M |
| September 25, 2026 | 620.88M |
| September 24, 2026 | 636.40M |
| September 23, 2026 | 622.95M |
| September 22, 2026 | 667.45M |
| September 21, 2026 | 658.13M |
| September 18, 2026 | 666.41M |
| September 17, 2026 | 681.93M |
| September 16, 2026 | 696.42M |
| Date | Value |
|---|---|
| September 15, 2026 | 716.08M |
| September 14, 2026 | 725.40M |
| September 11, 2026 | 723.84M |
| September 10, 2026 | 723.33M |
| September 09, 2026 | 745.06M |
| September 08, 2026 | 761.61M |
| September 04, 2026 | 782.31M |
| September 03, 2026 | 762.65M |
| September 02, 2026 | 776.10M |
| September 01, 2026 | 768.86M |
| August 31, 2026 | 742.99M |
| August 28, 2026 | 765.75M |
| August 27, 2026 | 796.80M |
| August 26, 2026 | 799.90M |
| August 25, 2026 | 809.21M |
| August 24, 2026 | 817.49M |
| August 21, 2026 | 807.14M |
| August 20, 2026 | 804.04M |
| August 19, 2026 | 806.11M |
| August 18, 2026 | 844.40M |
| August 17, 2026 | 794.73M |
| August 14, 2026 | 795.76M |
| August 13, 2026 | 791.62M |
| August 12, 2026 | 801.97M |
| August 11, 2026 | 831.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.316B |
| Oncolytics Biotech, Inc. | 62.14M |
| Sangamo Therapeutics, Inc. | 45.57M |
| Sarepta Therapeutics, Inc. | 2.025B |
| Anixa Biosciences, Inc. | 92.69M |
Market Cap Related Metrics
| Price to Book Value | 2.153 |
| Price | 6.56 |
| Earnings Yield | -27.11% |